Deccan Health Care Q1 FY27 Net Profit Drops 60% YoY

Revenue from Operations: Q1 FY27: ₹2,185.61; Q1 FY26: ₹2,026.49; Q4 FY26: ₹2,146.95; FY26: ₹8,917.10
Other Income: Q1 FY27: ₹2.57; Q1 FY26: ₹0.08; Q4 FY26: ₹0.62; FY26: ₹0.87
Total Income: Q1 FY27: ₹2,188.18; Q1 FY26: ₹2,026.57; Q4 FY26: ₹2,147.57; FY26: ₹8,917.97

Cost of Materials Consumed: Q1 FY27: ₹2,273.44; Q1 FY26: ₹1,658.80; Q4 FY26: ₹1,905.21; FY26: ₹6,292.54
Changes in Inventories: Q1 FY27: (₹75.48); Q1 FY26: (₹339.63); Q4 FY26: (₹361.27); FY26: (₹227.54)
Employee Benefit Expense: Q1 FY27: ₹120.64; Q1 FY26: ₹118.88; Q4 FY26: ₹136.37; FY26: ₹524.53
Finance Costs: Q1 FY27: ₹15.61; Q1 FY26: ₹14.33; Q4 FY26: ₹1.71; FY26: ₹36.61
Depreciation & Amortization: Q1 FY27: ₹38.60; Q1 FY26: ₹38.11; Q4 FY26: ₹40.55; FY26: ₹156.36
Other Expenses: Q1 FY27: ₹78.68; Q1 FY26: ₹511.30; Q4 FY26: ₹394.89; FY26: ₹1,839.98
Total Expenses: Q1 FY27: ₹2,155.39; Q1 FY26: ₹2,001.79; Q4 FY26: ₹2,117.46; FY26: ₹8,612.39

Profit Before Tax: Q1 FY27: ₹32.79; Q1 FY26: ₹24.78; Q4 FY26: ₹30.11; FY26: ₹305.58
Tax Expense: Q1 FY27: ₹8.16; Q1 FY26: ₹2.03; Q4 FY26: ₹8.86; FY26: ₹76.54
Current Tax: Q1 FY27: ₹11.74; Q1 FY26: ₹5.84; Q4 FY26: ₹13.17; FY26: ₹88.54
Deferred Tax: Q1 FY27: (₹3.58); Q1 FY26: (₹3.81); Q4 FY26: (₹4.31); FY26: (₹12.00)
Net Profit After Tax: Q1 FY27: ₹24.63; Q1 FY26: ₹22.75; Q4 FY26: ₹21.25; FY26: ₹229.04
Other Comprehensive Income: Q1 FY27: (₹0.28); Q1 FY26: (₹12.54); Q4 FY26: ₹3.80; FY26: (₹1.13)
Total Comprehensive Income: Q1 FY27: ₹24.35; Q1 FY26: ₹10.21; Q4 FY26: ₹25.05; FY26: ₹227.91

EPS Basic: Q1 FY27: ₹0.10; Q1 FY26: ₹0.09; Q4 FY26: ₹0.09; FY26: ₹0.93
EPS Diluted: Q1 FY27: ₹0.10; Q1 FY26: ₹0.09; Q4 FY26: ₹0.09; FY26: ₹0.93
Paid-up Equity Share Capital: ₹2,474.92 lakh (face value ₹10 each) across all periods

Cost of Materials Consumed: Q1 FY27: ₹2,265.81; Q1 FY26: ₹1,581.85; Q4 FY26: ₹1,911.56
Changes in Inventories: Q1 FY27: (₹745.48); Q1 FY26: (₹339.63); Q4 FY26: (₹361.27)
Employee Benefit Expense: Q1 FY27: ₹125.80; Q1 FY26: ₹121.19; Q4 FY26: ₹138.68
Finance Costs: Q1 FY27: ₹15.62; Q1 FY26: ₹14.33; Q4 FY26: ₹1.72
Depreciation & Amortization: Q1 FY27: ₹38.60; Q1 FY26: ₹38.11; Q4 FY26: ₹40.55
Other Expenses: Q1 FY27: ₹470.28; Q1 FY26: ₹645.05; Q4 FY26: ₹450.01
Total Expenses: Q1 FY27: ₹2,170.63; Q1 FY26: ₹2,060.90; Q4 FY26: ₹2,181.25

Profit Before Tax: Q1 FY27: ₹38.85; Q1 FY26: ₹36.70; Q4 FY26: ₹33.39
Tax Expense: Q1 FY27: ₹9.74; Q1 FY26: ₹3.30; Q4 FY26: ₹9.68
Current Tax: Q1 FY27: ₹13.32; Q1 FY26: ₹7.11; Q4 FY26: ₹13.99
Deferred Tax: Q1 FY27: (₹3.58); Q1 FY26: (₹3.81); Q4 FY26: (₹4.31)
Net Profit After Tax: Q1 FY27: ₹29.11; Q1 FY26: ₹33.40; Q4 FY26: ₹23.71
Other Comprehensive Income: Q1 FY27: (₹0.28); Q1 FY26: (₹12.54); Q4 FY26: ₹3.80
Total Comprehensive Income: Q1 FY27: ₹28.83; Q1 FY26: ₹20.86; Q4 FY26: ₹27.51

EPS Basic: Q1 FY27: ₹0.12; Q1 FY26: ₹0.14; Q4 FY26: ₹0.10
EPS Diluted: Q1 FY27: ₹0.12; Q1 FY26: ₹0.14; Q4 FY26: ₹0.10
Paid-up Equity Share Capital: ₹2,474.92 lakh (face value ₹10 each) across all periods

Beyoungstore Private Limited (subsidiary) contributed to consolidated results with total income of ₹259.44 lakh, profit after tax of ₹4.50 lakh, and total comprehensive income of ₹4.50 lakh for Q1 FY27.

The financial results were reviewed by statutory auditors Keyur Shah & Associates, who issued limited review reports for both standalone and consolidated results.
The company operates in a single segment - manufacturing of nutraceutical products.
No investor complaints were pending, received, disposed, or resolved during the quarter ended June 30, 2026.
Figures for quarter ended March 31, 2026 are balancing figures between audited annual figures and nine-month figures up to December 31, 2025.
Previous year's figures have been regrouped/rearranged/restated/adjusted/rectified/recasted where necessary.